Platinum
SD BIOSENSOR was established in 2010. Since then, there has been a continuous growth in the number of innovative products, production facilities and sales. Currently, 158 diagnostic assays are available selling globally to more than 517 distributors. We are working on research and development of immunological, molecular diagnostics and blood glucose self-monitoring system. We has been developing and manufacturing innovative diagnostic platforms that focus on; •Point of Care Testing •From screening tests to simple and reliable confirmatory tests
Covi-FERON products are Interferon Gamma Release Assay (IGRA) for detecting T cell-mediated immune responses to SARS-CoV-2 and its variants specific proteins. Advantage • Suitable for investigation of cellular immune response following SARS-CoV-2 natural infection and/or COVID-19 vaccination • Available for testing by variant group (Original SP Antigen tube: Wuhan/U.K, Variant SP Antigen tube: Brazil/South Africa)
This product is the fluorescent immunoassay for qualitative measurement of circulating neutralizing antibodies against SARS-CoV-2 in human serum and plasma. Advantage • High correlation with VNT (Virus neutralization test) • POCT type of neutralizing antibody test • Available for testing by variant group (Group 1: Wuhan/U.K, Group 2: Brazil/South Africa/Japan) • Rapid test result (35mins)
Versatile Point-of-Care Molecular Diagnostic System for infectious disease, drug resistance and genetic testing. Advantages • RT-PCR + LAMP in one system • Fast result out in 20-60 minutes • Scalable configuration up to 8 Modules • All-in-1 cartridge (NA extraction + Amplification)